Fullive.ai’s Somni Is Betting on AI That Learns Your Sleep Responses

Somni is Fullive.ai’s attempt to move beyond passive sleep tracking. Rather than simply reporting how a night went, the company is developing a screen-free bedside device that senses a person and their bedroom, makes limited changes to the environment, and uses the observed result to refine a later plan. Fullive calls this approach response learning. 58

That is an ambitious product thesis—but it is not the same as established clinical efficacy. The available reporting describes a device in development and a company seeking larger validation, so consumers should distinguish its intended capabilities from independently proven sleep or health outcomes. 5

The central idea: learn responses, not just sleep scores

Most sleep products focus on observation: measuring movement, sleep timing or other signals, then presenting a score or summary. Fullive’s proposed data loop is different:

1. Measure a state — collect signals from the sleeper and room.
2. Choose a bounded intervention — for example, an adjustment involving sound, light or scent.
3. Observe the response — assess what changes during the night and use that evidence in subsequent planning.

Fullive describes the resulting dataset as state → intervention → response. Its goal is to learn how a particular person responds to particular environmental inputs, rather than only classify their current condition. The company calls the model trained from that data a “response model.” 5

In practical terms, an ineffective pattern of sound or lighting would be changed on a later night, while a pattern associated with a better response could inform the next recommendation. That makes each night a small, constrained feedback cycle rather than a one-time sleep report. 5

What Somni is designed to sense

Somni is positioned as a non-wearable, screen-free bedside product for high-stress knowledge workers. Reporting on the device says it combines millimeter-wave radar, a microphone array and environmental sensors to monitor signals including breathing, heart rate, body movement and bedroom conditions overnight. 8

A bedside format is important to the product strategy. It avoids requiring someone to wear a device while sleeping and allows the system to observe both the person and the surrounding sleep environment. Fullive’s thesis is that a relatively stable bedroom, observed continuously for hours, is a practical place to begin learning personalized responses. 5

Still, non-contact sensing is a major area that requires transparent validation. Claims about physiological measurements should be assessed against accuracy benchmarks and clinical evidence, particularly when they may influence wellness or health decisions.

From sensing to intervention

The proposed intervention layer is what separates Somni from a conventional tracker. The device is intended to use sound, light and scent as environmental inputs, with goals such as supporting sleep onset, responding to nighttime waking and enabling a gentler wake-up experience. 58

Fullive says the system is designed to keep this action space limited rather than give a generative AI unrestricted control. In the company’s description, sensors feed a foundation-model-based planning layer, while its “Bio-OS Harness” coordinates sensing and output modules. It also describes confidence limits, evidence and a narrow intervention set as safety boundaries. 5

Those boundaries matter because personalized automation in a bedroom is not inherently beneficial simply because it is adaptive. A useful system needs to show that it can select interventions reliably, avoid disruptive choices and produce outcomes that hold up over time.

Why the company calls it a closed loop

A closed-loop product does more than collect data. It connects measurement, decision, action and feedback:

• Sense: detect signals from the sleeper and room.
• Infer: estimate the current state and relevant context.
• Act: use a constrained environmental intervention.
• Learn: compare the subsequent response with prior patterns and adjust a future strategy.

Fullive’s larger objective is to accumulate paired action-and-response data in real homes. The company argues that this evidence could eventually support an AI system that predicts how bodily states may change in response to environmental conditions. 5

That is a more difficult ambition than creating a sleep dashboard. It depends on separating meaningful effects from normal night-to-night variation, confounding factors and inaccurate sensor readings—questions that cannot be resolved by product usage alone.

Privacy claims should be treated as product claims

Fullive says radar raw waveforms are stored locally first, and that cloud-bound information is encrypted and minimized to avoid uploading raw data that could reconstruct personal privacy. 5

This is a relevant design goal for an always-present bedroom device, but it should not be interpreted as an independent privacy certification. Buyers and reviewers would need clear documentation on data retention, cloud processing, account controls, third-party sharing and security practices to evaluate the implementation.

The bigger goal: from sleep companion to “response model”

Fullive presents Somni as the first step in a broader platform strategy. The company says it plans to progress from sleep-focused trials and mass production toward larger clinical validation, then potentially expand into daytime products. Its long-term concept is a physiological “world model” that can anticipate and safely influence bodily state through the physical environment. 57

For now, that remains a research and product vision. The strongest evidence to watch will be independently designed clinical studies, published accuracy testing for non-contact sensing, and durable outcomes across varied users—not only company descriptions of how the system is intended to work. 5

What to watch next

Somni’s proposition is compelling because it shifts the goal from measuring sleep to testing whether small, personalized environmental changes can help. But the product’s value will rest on three unresolved questions:

• Can its non-contact sensors measure relevant signals accurately enough for individualized decisions?
• Do its sound, light and scent interventions improve meaningful sleep outcomes beyond ordinary variation or placebo effects?
• Can it demonstrate safety, privacy and lasting benefits in rigorous independent studies?

Until those questions are answered, Somni is best understood as an early AI-hardware bet on personalized recovery—not a validated medical solution. 58